Mytrex Health Technologies, Inc.

As of June 30, 2026, Mytrex Health Technologies, Inc. carries a market capitalization of 637.55M, placing it among publicly traded companies globally. Its enterprise value stands at 401.06M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Mytrex Health Technologies, Inc. has 36.54M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Mytrex Health Technologies, Inc. maintains a current ratio of 1.51, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Mytrex Health Technologies, Inc.'s stock has gained approximately 11.35% over the past 52 weeks. The 50-day moving average sits at 19.75, while the 200-day moving average is 18.08.

As of June 30, 2026, Mytrex Health Technologies, Inc. holds 419.87M in cash and equivalents against 183.39M in total debt, resulting in a net debt position of -299.13M. Total book value stands at 581.77M, with working capital of 284.59M providing operational flexibility.

Mytrex Health Technologies, Inc.'s most recent stock split took place on September 14, 2021 with a 2:3 split ratio.